Zusammenfassung
Die histologische Klassifikation erfolgt nach der überarbeiteten Fassung der Weltgesundheitsorganisation von 1981 [4]. Danach werden 3 Tumortypen nicht-kleinzelliger Karzinome unterschieden:
-
I.
Plattenepithelkarzinom (epidermoidales Karzinom) Variante: Spindelzelliges Plattenepithelkarzinom.
-
II.
Adenokarzinome
-
1.
azinäres Adenokarzinom
-
2.
papilläres Adenokarzinom
-
3.
bronchiolo-alveoläres Karzinom
-
4.
solides, schleimbildendes Adenokarzinom.
-
1.
-
III.
großzelliges Bronchialkarzinom
-
1.
großzelliges Karzinom mit Riesenzellen
-
2.
hellzelliges Bronchialkarzinom.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Becker N, Frentzel-Beyme R, Wagner G (1984) Krebsatlas der Bundesrepublik Deutschland, 2. Aufl. Springer, Berlin Heidelberg New York Tokyo
Boring CC, Squires TS, Tong T (1993) Cancer Statistics 1993. CA/Cancer J Clin 43: 7–26
Zeller WJ, Schmähl D (1985) Ätiologie des Bronchialkarzinoms. In: Trandelenburg F (Hrsg) Tumoren der Atmungsorgane und des Mediastinums. Handbuch der Inneren Medizin IV/4A. Springer, Berlin Heidelberg New York, 51–86
World Health Organization (1982) The World Health Organization Histological Typing of Lung Tumors, 2nd edn. Am J Clin Pathol 77:123–136
Müller KM, Fisseler-Eckhoff A (1991) Pathologie der Lungentumoren. In: Drings P, VogtMoykopf I (Hrsg) Thoraxtumoren Diagnostik-Staging-gegenwärtiges Therapiekonzept. Springer, Berlin Heidelberg New York, 5–24
Hermanek P, Sobin H (eds) (1987) TNM Classification of Malignant Tumors. 4th ed. International Union Against Cancer, Geneva
Drings P, Vogt-Moykopf I (1988) Das nicht-kleinzellige Bronchialkarzinom. Deutsches Ärzteblatt 85: 2146–2151
Bülzebruck H, Bopp R, Drings P et al. (1992) New Aspects in the Staging of Lung Cancer. Cancer 70: 1102–1110
Vogt-Moykopf I, Krysa S, Probst G et al. (1991) Pathologie der Lungentumoren. In: Drings P, Vogt-Moykopf I (Hrsg) Thoraxtumoren Diagnostik-Staging-gegenwärtiges Therapiekonzept. Springer, Berlin Heidelberg New York, 170–186
Vogt-Moykopf 1 (1993) Persönliche Mitteilung
Kimmig B, Vogel D, Flentje M, Wannenmacher M (1991) Pathologie der Lungentumoren. In: Drings P, Vogt-Moykopf I (Hrsg) Thoraxtumoren Diagnostik-Staging-gegenwärtiges Therapiekonzept. Springer, Berlin Heidelberg New York, 199–211
Kuttig H (1986) Palliative Radiotherapie der nicht-kleinzelligen Bronchialkarzinome. In: Drings P, Schmähl D, Vogt-Moykopf I (Hrsg) Bronchialkarzinom, Aktuelle Onkologie 26. Zuckschwerdt, München Bern Wien, 366–379
Joss PA, Brunner KW (1985) Die Chemotherapie der nicht-kleinzelligen Bronchialkarzinome. In: Seeber S, Niederle N (Hrsg) Interdisziplinäre Therapie des Bronchialkarzinoms. Springer, Berlin, 75–94
Bakowski MT, Crouch JC (1983) Chemotherapy for Non-Small Cell Lung Cancer. A Reappraisal and a Look to the Future. Cancer Treatm Rep 10: 159–172
Sculier JP, Klastersky J (1984) Progress in Chemotherapy of Non-Small Cell Lung Cancer. Europ J Cancer Clin Oncol 20: 1329–1333
Hazuka MB, Bunn PA (1992) Controversies in the Nonsurgical Treatment of Stage III Non-Small Cell Lung Cancer. Am Rev Respir Dis 145: 967–977
Folman RS, Rosman M (1988) The Role of Chemotherapy in Non-Small Cell Lung Cancer: The Community Perspective. Sem Oncol 15: 16–21.
Eberhardt W, Niederle N (1992) Ifosfamide in Non-Small Cell Lung Cancer: a Review. Sem Oncol 19: 40–48
Haraf DJ, Devine S, lhde DC, Vokes EE (1992) The Evolving Role of Systemic Therapy in Carcinoma of the Lung. Sem Oncol 19: 72–87
Ihde DC (1992) Chemotherapy of Lung Cancer. New Engl J Med 327: 1434–1441
Sandler AB, Buzaid AC (1992) Lung Cancer: A Review of Current Therapeutic Modalities. Lung 170: 249–265
Aaronson NK, Bullinger M, Ahmedzai S (1988) A Modular Approach to Quality-of-Life Assessment in Cancer Clinical Trials. Recent in Cancer Research 111:231–249. Springer, Berl in Heidelberg
Lung Cancer Study Group (1988) The Benefit of Adjuvant Treatment for Resection of Locally of Advanced Non-Small Cell Lung Cancer. J Clin Oncol 6: 9–17
Rose LJ (1991) Neoadjuvant and Adjuvant Therapy of Non-Small Cell Lung Cancer. Sem Oncol 18: 536–542
Strauss GM, Langer MP, Elias AD et al. (1992) Multimodality Treatment of Stage Ill A Non-Small Cell Lung Carcinoma: A Critical Review of the Literature and Strategies for Future Research. J Clin Oncol 10: 829–838
Schaake-Koning C, van den Bogaert W, Dalesio O et al. (1992) Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small Cell Lung Cancer. New Engl J Med 326: 524–530
Rapp E, Pater JL, Willan A et al. (1988) Chemotherapy Can Prolong Survival in Patients with Advanced Non-Small Cell Lung Cancer–Report of a Canadian Multicenter Randomized Trial. J Clin Oncol 6: 633–641
Wilke H, Achterrath W, Gunzer U et al. (1987) Etoposide and Split Dose of Cisplatin. A Phase Il Study in Non-Small Cell Lung Cancer (NSCLC) Tumor Diagnostik und Therapie 8: 194–198
Longeval E, Klastersky J (1982) Combination Chemotherapy with Cisplatin and Etoposide in Bronchogenic Squamous Cell Carcinoma and Adenocarcinoma. Cancer 50: 2751–2756
Gralla RJ, Casper ES, Kelsen DP et al. (1981) Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating two Dosage Schedules. Ann Intern Med 95: 414–420
Drings P, Abel U, Bülzebruck H et al. (1986) Experience with Ifosfamide Combinations (Etoposide or DDP) in Non-Small Cell Lung Cancer. Cancer Chemother Pharmacol 18 (Suppl 2): 34–39
Shephard FA, Evans WK, Goss PE et al. (1992) Ifosfamide, Cisplatin and Etoposide ( ICE) in the Treatment of Advanced Non-Small Cell Lung Cancer. Sem Oncol 19: 54–58
Shirinian M, Lee JS, Dhingra HH et al. (1992) Phase II Study of Cisplatin, Ifosfamide with Mesna and Etoposide ( PIE) Chemotherapy for Advanced Non-Small Cell Lung Cancer. Sem Oncol 19: 49–53
Cullen MH, Joshi R, Chetiyawardana AD, Woodroffe CM (1988) Mitomycin, Ifosfamide and Cisplatin in Non-Small Cell Lung Cancer: Treatment Good Enough to Compare. Br J Cancer 58: 359–361
von Rohr A, Anderson H, McIntosh R, Thatcher N (1991) Phase II Study with Mitomycin, Ifosfamide and Carboplatin in Inoperable Non-Small Cell Lung Cancer. Eur J Cancer 27: 1106–1108
Wolf M, Havemann K, Stalleicken D et al. (1988) Ergebnisse zweier multizentrischer Therapiestudien beim inoperablen nicht-kleinzelligen Bronchialkarzinom. Onkologie 11: 222–231
Kris MG, Gralla RJ, Wertheim MS et al. (1986) Trial of the Combination of Mitomycin, Vindesine and Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer. Cancer Treat Rep 70: 1091–1096
Miller TP, Vance RB, Ahmann FR, Rodney SR (1986) Extensive Non-Small Cell Lung Cancer Treated with Mitomycin, Cisplatin and Vindesine (MiPE): A Southwest Oncology Group Study. Cancer Treat Rep 70: 1101–1104
Sculier JP, Klastersky J, Dumont JP et al. (1986) Combination Chemotherapy with Mitomycin and Vindesine in Advanced Non-Small Cell Lung Cancer: A Pilot Study by the Lung Cancer Working Party ( Belium ). Cancer Treat Rep 70: 773–775
Gatzemeier U, Hossfeld DK, Magnussen H et al. (1987) Combination Chemotherapy with Mitomycin C, Ifosfamide and Vindesine in the Treatment of Non-Small Cell Lung Cancer. Contr Oncol 26: 375–383
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Drings, P. (1993). Nicht-kleinzelliges Bronchialkarzinom. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10495-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-662-10495-8_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56872-8
Online ISBN: 978-3-662-10495-8
eBook Packages: Springer Book Archive